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Involvement of the FKBP5 gene in the 
pathogenesis of stress-related disorders 




events are increasingly recognized as important environmental 
ǡ	ͷ
a candidate gene in research on stress-related conditions. This 
review aims to provide a concise overview of current knowledge 
	ͷ
directions for future research. Firstly, the functional role of the 
   Ǥ     Ǧ
traumatic stress disorders will then be discussed in the context 
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INTRODUCTION
Psychiatric disorders are the result of an interplay between genetic and environmental 
ƪǤ        
pathophysiological mechanisms, as well as development of new treatment 
Ǥ	͜͢͡͡͝ȋ	͡Ȍ
gene for stress-related conditions due to its role in the regulation of neurobiological 
stress responses. Initial evidence of pathophysiological implications of the FKBP5 
gene dates back to the early 2000’s (Binder, Salyakina, & Lichtner, 2004; Fallin et 
al., 2005; Koenen et al., 2005), but it was not until the publication of a seminal 
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review paper (Binder, 2009) that interest in this gene has started to grow. Since then, 
several lines of research have provided new evidence on the involvement of the 
FKBP5 gene in stress-related conditions and drug response, shifting the focus from 
ơǦǦȋ
ȌǤ
the scope and the implications of this change of paradigms, an updated overview of 
the latest research on the FKBP5 gene is required. 
     Ƥ   	͡     
updating the existing knowledge about its involvement in stress-related disorders. 
Firstly, an overview on the functional role of FKBP5 in glucocorticoid-signaling will 
be provided. Secondly, focus will be placed on associations between the FKBP5 gene 
ơǡǦȋȌǤ
Even though such stress-related conditions share underlying pathophysiology, 
 ƪ      Ǥ
Finally, reports of the FKBP5 gene as a biomarker of antidepressant treatment 




5. Only human studies were included in the review. Table 1 provides an overview of 
the key studies investigating the link between the FKBP5 gene and stress-related 
conditions. Table 2 includes reports examining the associations between FKBP5 
polymorphisms and response to antidepressant drug treatment. 
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FKBP5 rs1360780 did not predict response 
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		͡
ǧ
GLUCOCORTICOID-SIGNALING AND FKBP5 FUNCTION
  ơ  ȋǦȌ    
determines an individual’s susceptibility to psychiatric disorders (Mehta & Binder, 
2012). The physiological stress response plays a central role in coping with negative 
Ǥơǡ
hypothalamic-pituitary-adrenal (HPA) axis, are therefore of particular interest in 
the detection of risk factors for stress-related conditions (Spijker & van Rossum, 
2012).  
 Stress induces the release of corticotropin releasing hormone from the 
paraventricular nucleus in the hypothalamus, which stimulates pituitary 
adrenocorticotrophine hormone synthesis, in turn increasing the release of 
glucocorticoids from the adrenal cortex (Mehta & Binder, 2012). Glucocorticoids 
participate in the termination of stress response via the activation of glucocorticoid 
receptors (GR), a ligand-activated transcription factor that promotes negative 
feedback inhibition of the HPA-axis. Upon cortisol-binding, GR translocates from 
the cytosol to the cell nucleus, where it exhibits its transcription and translation 
actions. GR function is modulated by a molecular hetero-complex that comprises 
hsp90/hsp70 chaperones and a number of co-chaperones, including FKBP5. When 
	͡    
 ǡ     ƥ  ǡ
leading to a reduction of the amount of activated GR translocation and cellular 
glucocorticoid resistance (i.e. reduced glucocorticoid sensitivity) (Hartmann et al., 
2012). Glucocorticoids induce FKBP5 expression as a part of an intracellular ultra-
short negative feedback loop for GR activity (Binder, 2009; Hartmann et al., 2012). 
 Proper termination of physiological stress responses after stressor exposure 
is necessary for a healthy regulation, and prolonged or excessive activation of 
the HPA-axis has been implicated in the pathogenesis of stress-related disorders 
(Binder, 2009; Mehta & Binder, 2012). For example, impaired GR signaling results in 
an attenuation of the negative feedback inhibition. This can lead to glucocorticoid 
resistance and HPA-axis hyperactivity, two alterations commonly observed in mood 
disorders (Binder, 2009; Menke et al., 2012; Spijker & van Rossum, 2012). On the 
other hand, an increase in GR sensitivity due to enhanced negative feedback is 
observed in anxiety disorders such as PTSD (Mehta et al., 2011; Sarapas et al., 2011; 
van Zuiden et al., 2012; Yehuda et al., 2009).
FKBP5 POLYMORPHISMS AND THEIR FUNCTIONAL ROLE IN GR 
SIGNALING
 ơ  Ǧ       Ȁ
ơȋǤǤǡǡ
trauma exposure) that alter the baseline response to this system (Mehta & Binder, 
2012). Indeed, GR-related genes have been shown to shape the physiological stress 
responsiveness (Mahon, Zandi, Potash, Nestadt, & Wand, 2013; Menke et al., 2012). 





example, common single-nucleotide polymorphisms (SNPs) of the FKBP5 gene 
have been associated with higher FKBP5 protein/mRNA expression and increased 
GR resistance, leading to impaired negative feedback inhibition of the HPA-axis 
after exposure to psychosocial stressors (Binder, Bradley, & Liu, 2008; Ising et al., 
2008; Lekman et al., 2008; Mahon et al., 2013; Touma et al., 2011). 
 Importantly, this genetic association with GR function appears to be state-
ǡ    Ƥ     ơ 
 
depending on the disease-status of the individual. For example, the minor allele 
of polymorphisms initially associated with high FKBP5 induction in healthy 
 ȋǤǤǡ ͣͤ͟͢͜͜͝Ȍ      	͡  
and GR hypersensitivity in patients with depression (Menke et al., 2013) or PTSD 
(Mehta et al., 2011; Sarapas et al., 2011). Mehta et al. (2011) hypothesized that this 




early life stress exposure and FKBP5 SNPs on the risk of developing stress-related 
ȋǤǡ͜͟͞͝ȌǤǦƤ	͡
methylation in response to childhood abuse were shown to alter the responsiveness 




gene and GR function. In a study by Mahon et al. (2013) only male participants 
showed a positive genetic association with high cortisol levels in response to acute 
ǤǦƤơƪ
hormones on FKBP5 and other GR-related genes (Binder, 2009). Nevertheless, sex-
Ƥơ	͡ȋ
et al., 2008; Ising et al., 2008; Luijk et al., 2010).
FKBP5 AND RISK FOR STRESS-RELATED PSYCHIATRIC CONDITIONS
Mood disorders
Consistent with abnormalities in the HPA-axis feedback regulation and GR 
  ơ ǡ 
Ǧ ǡ  	͡ǡ  
implicated in their pathogenesis (Binder, 2009; Spijker & van Rossum, 2012). In 
ǡ	͡Ǧơ

in patients with major depression, suggesting that the FKBP5 gene might delineate 
neuroendocrinologically distinct subtypes of depression (Menke et al., 2013).
 High risk of developing depressive symptoms has been associated with FKBP5 
polymorphisms (Lavebratt, Aberg, Sjöholm, & Forsell, 2010; Lekman et al., 2008; 
  Ǥǡ ͜͞͝͝Ǣ   Ǥǡ ͜͜͞͝ȌǤ ǡ    
regarding the concrete genotypes that increase the vulnerability to depression. While 
some studies support a model in which carriers of the minor alleles are at higher 




over-representation of major alleles in patients with depression (Zobel et al., 2010). 
In the same direction, a correlation between change in the severity of depressive 
	͡Ǧǡ
but only in those homozygous for the major allele (i.e. carriers of two copies of the 
major allele) of the FKBP5 SNP examined (Tatro et al., 2010). 
 ơ
were detected have not been replicated in several other studies (Appel et al., 2011; 
Binder et al., 2004; Kang et al., 2012; Lewis, Collishaw, Harold, Rice, & Thapar, 
2012; Shinozaki et al., 2011; Zimmermann et al., 2011). For example, Binder et al. 
(2004) found an association between FKBP5 genotype and lifetime depressive 
ǡ     ơ     
with depression and controls. Furthermore, a comprehensive meta-analysis that 
evaluated the relationship between FKBP5 polymorphisms and mood disorders 
yielded only one positive association (Feng et al., 2011). As an explanation of lack of 
consistent replication, the importance of FKBP5 gene-by-environment interactions 
in depression has been highlighted (Appel et al., 2011; Kang et al., 2012; Shinozaki et 
al., 2011; Zimmermann et al., 2011).
 Early stressful events have been shown to increase the susceptibility to mood 
disorders in adulthood (Zimmermann et al., 2011), and FKBP5 gene seems to 
ǤǤȋ͜͞͝͝ȌƤ
childhood abuse and FKBP5 genotype on the severity of adult depressive symptoms 
 Ǥ Ƥǡ   
vulnerability to depression only in homozygous for the minor allele of the SNP 
Ǥ   ơǡ ǡ     
ǡ	͡ơǦ
stress (Appel et al., 2011). 
 An interaction between adverse life events and FKBP5 polymorphisms was 
also observed in a prospective longitudinal community study (Zimmermann et al., 
͜͞͝͝ȌǤƤ	͡
developing a major depressive episode in individuals with prior trauma exposure. 
ǡǦǡơ
with increasing trauma severity. These results were replicated in one of the two 
additional independent samples analyzed in this study. 
 	͡ơǦ
ƪ	͡
on the development of depression after relatively uniform stressful experiences, 
such as diagnosis and treatment of severe medical conditions. Shinozaki et al. (2011) 
and Kang et al. (2012) found that FKBP5 polymorphisms predicted the development 
of depressive symptoms after kidney transplant or two cycles of chemotherapy. 
Nonetheless, results reported in the study by Shinozaki et al. (2011) should be 
interpreted carefully since no correction for multiple comparisons was applied and 
there were no data about the pre-transplant depression status.
 Ƥ
ǡ
failed to provide support to this relationship. A common FKBP5 polymorphism did 
not modulate the risk for depression in individuals exposed to childhood problems 
126
TRILLA
or negative life events during the previous year (Lavebratt et al., 2010). Similarly, 
FKBP5 genotype did not interact with recurrent maternal depression to increase 
the vulnerability to child and adolescent depression (Lewis et al., 2012). Besides the 
Ƥ

power, or that they might not be applicable to the FKBP5 SNPs studied, it is likely 
that FKBP5 is only sensitive to certain types of severe psychosocial stressors (Appel 




reports might be due to the presence of high rates of trauma in the study samples, 
as most of those studies were based on clinical samples (e.g., Lavebratt et al., 2010; 
Lekman et al., 2008; Tatro et al., 2010; Zobel et al., 2010) in which early stressful 
events tend to be high (Appel et al., 2011; Zimmermann et al., 2011). 
 Evidence for an association between the FKBP5 gene and bipolar disorder is 






FKBP5 seems to be also involved in the pathophysiology of suicidal behavior. 
Haplotypes of the FKBP5 gene have been associated with completed suicide in a 
Japanese sample (Supriyanto et al., 2011), although due to the lack of the psychiatric 
          Ƥ  
ơ	͡
pathologies associated with suicide. To disentangle this issue, Pérez-Ortiz, Garía-
Gutiérrez, Navarrete, Giner, & Manzanarez (2013) examined FKBP5 expression in 
the amygdala of suicide victims without any underlying psychiatric disorder and 
Ƥ	͡
to controls, thus implicating FKBP5 in the neurobiological mechanisms of suicidal 
behavior. 
 G x E studies suggest a moderating role of FKBP5 genotype in the association 
between childhood trauma and suicide (Roy, Gorodetsky, Yuan, Goldman, & Enoch, 
2010; Roy, Hodgkinson, Deluca, Goldman, & Enoch, 2012). In other words, childhood 
trauma exposure increased the risk of attempting suicide only in carriers of certain 
FKBP5 allelic-variants or haplotypes.
Post-traumatic stress disorder
Both stressful life events (e.g., childhood trauma) and GR-related genes have 
   ơ Ǧ ǡ    ǡ  
stress regulation are present in PTSD (Mehta & Binder, 2012). In addition, PTSD 
is the only psychiatric disorder in the Diagnostic and Statistical Manual of Mental 
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		͡
ǧ
G x E vulnerability factors for PTSD, see Mehta & Binder, 2012).
           ơ  	͡
polymorphisms on the risk to develop PTSD after early trauma exposure. Binder et al. 
(2008) detected four FKBP5 SNPs that interacted with child abuse to predict PTSD 
symptomatology in adulthood in a population of mostly African-Americans. In this 
sample, the non-risk alleles exerted a protective action against the development 
of adult PTSD after severe child abuse in a gene dose-dependent manner, that is, 
carriers of two non-risk alleles reported lower PTSD symptoms than carriers of only 
ǦǤơ	͡
childhood trauma and PTSD has been replicated in African Americans (Mehta et 
Ǥǡ͜͞͝͝ǢǤǡ͜͜͞͝ȌȋǤǡ͜͜͞͝ȌǤ
of associations observed in the European American cohort might be due to ethnic-





importance of G x E interactions in stress-related conditions.
 FKBP5 polymorphisms have also been associated with peritraumatic 
dissociation (i.e. dissociative experiences such as depersonalization and 




baseline cortisol levels and whole-blood gene expression pattern were associated 
with FKBP5 genotype in a sample of patients with PTSD (Mehta et al., 2011). 
 Reduced FKBP5 gene expression has been proposed as a state marker of 
PTSD (Sarapas et al., 2011; Yehuda et al., 2009) and it predicted high levels of PTSD 
symptoms in response to military deployment in a prospective study (van Zuiden et 
al., 2012). Interestingly, clinical response to cognitive behavioral therapy has been 
associated with normalization of the FKBP5 gene expression levels in patients with 
PTSD (Levy-Gigi, Szabó, Kelemen, & Kéri, 2013).
ANTIDEPRESSANT DRUG RESPONSE
Ƥ͞ ͜͜͠	͡
response to antidepressant drug treatment (Binder et al., 2004), several replication 
pharmacogenetic studies have found both positive and negative associations 
between FKBP5 markers and antidepressant response across independent samples 
(Ellsworth et al., 2013; Horstmann et al., 2010; Lekman et al., 2008; Niitsu, Fabbri, 
Bentini, & Serretti, 2013; Sarginson, Lazzeroni, Ryan, Schatzberg, & Murphy, 2010; 
Tsai, Hong, Chen, & Yu, 2007; Zobel et al., 2010). Associations between FKBP5 SNPs 
and remission of depressive symptoms and response to treatment with selective 
serotonin reuptake inhibitors (SSRIs) have been found in both the STAR*D cohort 
and the Mayo study (Horstmann et al., 2010; Lekman et al., 2008). Positive FKBP5 
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genetic associations with antidepressants response were also reported in a recent 
comprehensive meta-analysis on pharmacogenetics in major depression (Niitsu 
et al., 2013). Furthermore, FKBP5 allelic-variants predicted smaller hippocampal 
volume and lack of reduction of HPA-axis hyperactivity after SSRI treatment (Zobel 
et al., 2010), two indicators of clinical non-response. However, none of the FKBP5 
SNPs tested in this study predicted change in the severity of depression (Zobel et 
al., 2010). 
 Data challenging the strong genetic associations initially reported comes from 
Ǥǡȋͣ͜͜͞ȌǤȋ͜͜͞͝Ȍǡ	͡ơ
ƥǤǡ	͡
commonly found to be associated with clinical improvements after antidepressant 
 ȋǤǤ ͣͤ͟͢͜͜͝ǡ ͤͣ͟͜͜͟͟  ͣͥ͟͢͠͝͝Ȍ     
response in a recent report (Ellsworth et al., 2013). 
 Several factors might explain the discrepancies between the described 
ƤǤ	ǡơ
or subtypes of patients. For instance, Binder et al. (2004) included inpatients with 
major depression, bipolar and dysthymic disorders in the sample, whereas the study 
group in Sarginson et al. (2010) consisted of elderly outpatients diagnosed with 
major depression. The ethnic origin of the study sample is another factor that might 
account for the divergent results, since certain genetic associations have been found 
in Caucasians and White non-Hispanics but not in African-American population 
nor in other ethnic subgroups (e.g., Lekman et al., 2008; Niitsu et al., 2013; Tsai 
et al., 2007). Finally, some of the studies have followed a naturalistic approach in 
which patients were treated according to doctors’ choice (e.g., Binder et al., 2004; 
Horstmann et al., 2010), while in others a standardized routine treatment with a 
ƤȋǤǤǡǤǡ͜͟͞͝ǢǤǡͤ͜͜͞Ǣ





have a more important role in the pharmacogenetics of antidepressant drugs. 
	ǡǤ ȋ͜͜͞͝Ȍ  Ƥ 





of the variance of treatment response than models considering only genetic main 
ơǤ 	ǡ   
high FKBP5 gene expression levels in patients with depression that successfully 
responded to the treatment, although there was no association between baseline 
FKBP5 mRNA levels and treatment response (Cattaneo et al., 2013).
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CONCLUSIONS AND FUTURE DIRECTIONS
In the last years, several lines of research have implicated the FKBP5 gene in the 
etiology of stress-related phenomena. Consistent evidence supports associations 
between the FKBP5 polymorphisms and depression, suicidal behavior and PTSD. 
However, additional replication studies are warranted to provide conclusive data on 
the role of this gene in bipolar disorder and other conditions. For example, a recent 
report suggests that FKBP5 polymorphisms might also confer risk for psychotic 
experiences (Collip et al., 2013). The use of endophenotype-based approaches in 
addition to the classic genetic association studies will aid attempts to further link the 
FKBP5 gene to psychiatric disorders. In fact, some studies have already implicated 
the FKBP5 gene in endophenotypes associated with stress-related psychopathology, 
such as increased amygdala reactivity (White et al., 2012) and limbic system 
irritability after childhood trauma (Dackis, Rogosch, Oshri, & Cicchetti, 2012), as 
well as attention bias for threat and hippocampal alterations (Fani et al., 2013).
 Increasing evidence highlights the importance of G x E studies for the 
detection of risk factors of stress-related psychopathology. Indeed, interaction 
between FKBP5 polymorphisms and early life stress exposure, rather than direct 
ơǡǡ
and suicide behavior. Importantly, the modulatory role of FKBP5 gene might not 
ǡƤơ
trauma-related stress. Upcoming epigenetic studies will contribute to elucidating 
mechanisms by which the interaction of FKBP5 gene and childhood trauma 
increases the susceptibility to mood disorders and PTSD. 
  Ƥ      	͡ 
and allelic-variants that increase the vulnerability to stress-related disorders are 
commonly reported. It is possible that, due to the high linkage disequilibrium in the 
FKBP5 gene and variations in allele frequencies by ethnicity (Binder, 2009), some 
ƪ
ǡƤǤǡ
little is known about the functional impact of the FKBP5 polymorphisms on GR 
signaling. Future studies should therefore address these issues to better identify 
ơ
backgrounds vulnerable to stress-related disorders. Moreover, detailed knowledge 
about the functional properties of FKBP5 polymorphisms might facilitate the 
Ƥǡ
lead to advances in the diagnosis and treatment of these disorders. 
 Finally, FKBP5 polymorphisms have also been demonstrated to play a 
promising role in pharmacogenetics of antidepressant drugs. For instance, FKBP5 
genotype could potentially be harnessed as biomarker of SSRI response. However, 
more research is needed to fully resolve the involvement of the FKBP5 gene in the 
response to antidepressant treatment, with special focus on G x G interactions. 
 To sum up, gaining further knowledge of the FKBP5 gene could improve 
understanding and treatment of stress-related disorders that might be useful for 
future interventions. To this end, it might be advantageous not just to consider the 
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